[go: up one dir, main page]

Next Article in Journal
Efficacy of Eggshell Membrane in Knee Osteoarthritis: A Systematic Review and Meta-Analysis
Previous Article in Journal
Estimating the Potential Health Care Cost-Savings from a Flax-Based Treatment for Hypertension
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Influence of Genetic Polymorphisms on Cognitive Function According to Dietary Exposure to Bisphenols in a Sample of Spanish Schoolchildren

by
Viviana Ramírez
1,2,3,4,†,
Patricia González-Palacios
1,3,
Pablo José González-Domenech
5,
Sonia Jaimez-Pérez
6,
Miguel A. Baca
7,
Lourdes Rodrigo
8,
María Jesús Álvarez-Cubero
2,3,9,*,†,
Celia Monteagudo
1,3,*,†,
Luis Javier Martínez-González
2,9,† and
Ana Rivas
1,3,4,†
1
Department of Nutrition and Food Science, Faculty of Pharmacy, University of Granada, 18071 Granada, Spain
2
GENYO Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government PTS Granada—Avenida de la Ilustración, 114, 18016 Granada, Spain
3
Instituto de Investigación Biosanitaria ibs.GRANADA, 18012 Granada, Spain
4
Institute of Nutrition and Food Technology “Jose Mataix Verdú”, Biomedical Research Center, Health Sciences Technological Park, University of Granada, 18016 Granada, Spain
5
Department of Psychiatry, Faculty of Medicine, University of Granada, 18012 Granada, Spain
6
Virgen de las Nieves University Hospital, 18014 Granada, Spain
7
Clinica MenSana, 18009 Granada, Spain
8
Department of Legal Medicine, Toxicology and Physical Anthropology, Faculty of Medicine, University of Granada, 18012 Granada, Spain
9
Department of Biochemistry and Molecular Biology III, Faculty of Medicine, University of Granada, 18012 Granada, Spain
*
Authors to whom correspondence should be addressed.
These authors contributed equally to this work.
Nutrients 2024, 16(16), 2639; https://doi.org/10.3390/nu16162639 (registering DOI)
Submission received: 23 July 2024 / Revised: 7 August 2024 / Accepted: 8 August 2024 / Published: 10 August 2024
(This article belongs to the Section Nutrigenetics and Nutrigenomics)

Abstract

:
Background: Neurodevelopmental disorders (NDDs) like intellectual disability (ID) are highly heritable, but the environment plays an important role. For example, endocrine disrupting chemicals (EDCs), including bisphenol A (BPA) and its analogues, have been termed neuroendocrine disruptors. This study aimed to evaluate the influence of different genetic polymorphisms (SNPs) on cognitive function in Spanish schoolchildren according to dietary bisphenol exposure. Methods: A total of 102 children aged 6–12 years old were included. Ten SNPs in genes involved in brain development, synaptic plasticity, and neurotransmission (BDNF, NTRK2, HTR2A, MTHFR, OXTR, SLC6A2, and SNAP25) were genotyped. Then, dietary exposure to bisphenols (BPA plus BPS) was estimated and cognitive functions were assessed using the WISC-V Spanish form. Results: BDNF rs11030101-T and SNAP25 rs363039-A allele carriers scored better on the fluid reasoning domain, except for those inheriting the BDNF rs6265-A allele, who had lower scores. Secondly, relevant SNP–bisphenol interactions existed in verbal comprehension (NTRK2 rs10868235 (p-int = 0.043)), working memory (HTR2A rs7997012 (p-int = 0.002), MTHFR rs1801133 (p-int = 0.026), and OXTR rs53576 (p-int = 0.030)) and fluid reasoning (SLC6A2 rs998424 (p-int = 0.004)). Conclusions: Our findings provide the first proof that exploring the synergistic or additive effects between genetic variability and bisphenol exposure on cognitive function could lead to a better understanding of the multifactorial and polygenic aetiology of NDDs.

Graphical Abstract">

Graphical Abstract

1. Introduction

DSM-V (Diagnostic and Statistical Manual of Mental Disorders, fifth edition) defines neurodevelopmental disorders (NDDs) as a heterogenous group of mental health conditions that occur during the developmental period and negatively affect brain functioning [1]. NDDs include attention-deficit hyperactivity disorder (ADHD), autism spectrum disorder (ASD), and intellectual disability (ID), which lead to behavioural problems, poorer learning, memory dysfunction, and delayed motor development [2,3]. Among these, cognitive impairments in general and ID in particular constitute major conditions of NDDs with diverse aetiologies, affecting about 1% of children in the world [4,5]. They are characterised by both impaired cognitive functioning (intellectual quotient (IQ) < 70) and adaptive behaviour [6].
Non-genetic causes such as infections, autoimmunity, and environmental factors are described in NDD pathogenesis, but advances in biomolecular knowledge (e.g., genotyping/sequencing approaches) have identified hundreds of candidate genes to be involved in neurodevelopment, revealing the importance of a genetic contribution [7,8]. In fact, ID has emerged as the most common manifestation under genetic abnormalities [5,9]. Structural variants such as copy number variations (CNVs) and point mutations like single nucleotide variants (SNVs) have been found in patients suffering from neurodevelopmental alterations [10]. In certain cases, one single de novo mutation could be the causative factor, while in other scenarios, the risk of developing NDDs could be influenced by a complex interplay between rare and common genetic variants [7]. Specifically, single nucleotide polymorphisms (SNPs), which are common SNVs occurring with a frequency of at least 1%, have shown to contribute to mild intellectual impairment [11]. Brain-derived neurotrophic factor (BDNF) rs6265 (Val66Met) is one of the most extensively studied missense variants within the prodomain region of BDNF, with functional consequences on memory, cognition, and behaviour [12].
Although the identification of NDD-causing genes is essential for understanding the underlying biological mechanisms responsible for the onset of these disorders, the molecular diagnosis is quite challenging and still unknown in many patients [2]. This highlights the complex and multifactorial nature of NDDs and the need to examine other risk factors at the same time. Endocrine disrupting chemicals (EDCs) such as bisphenol A (BPA) and its analogues are able to cross the blood–brain barrier and, as the developing brain is particularly sensitive to these compounds, EDCs have been termed neuroendocrine disruptors [13]. BPA migration from food packaging into foodstuffs is a significant contamination source by which BPA enters the food chain, and for this reason, dietary consumption has been considered the primary contributor to BPA exposure, followed by contaminated air and dermal absorption [14]. To date, BPA exposure during childhood has been more frequently related to adverse behavioural outcomes, whereas evidence for effects on cognitive functioning is still weak [15,16]. For this reason, the exploration of the synergistic or additive effect between the environmental factor and genetic vulnerability could lead to a better understanding of the multifactorial and polygenic aetiology of NDDs [17,18]. To the best of our knowledge, there is growing evidence of interactions between gene polymorphisms and pesticides/heavy metals in cognitive development and the etiopathogenesis of disorders such as ASD and ADHD [10]; nonetheless, no human studies examining NDD-associated genetic variants in the presence of bisphenol exposure are available.
Therefore, the purpose of the current study was to evaluate the influence of different genetic polymorphisms on cognitive function in Spanish schoolchildren aged between 6 and 12 years according to dietary exposure to bisphenols.

2. Materials and Methods

2.1. Study Subjects and Data Collection

Participants enrolled in this study were recruited from different elementary schools and health centres in Granada, Spain, between 2020 and 2023 as part of a larger research project. Inclusion criteria for the selection of the study population were (1) schoolchildren aged between 6 and 12 years, and (2) having lived in the study area for at least 6 months continuously. Children whose parents or legal tutors agreed to participate and signed the written informed consent form were contacted by the paediatric clinical centre specialised in neurodevelopmental disorders. The study protocol was approved by the Ethics Committee of Provincial Biomedical Research of Granada (1742-N-23).
A total of 102 children with available estimates of dietary exposure to bisphenols, good quality DNA samples, and neurodevelopmental tests assessing cognitive function were finally selected for the current study.
Face-to-face interviews were conducted with all participants’ parents or guardians by trained interviewers. The structured questionnaire was based on a sociodemographic section (gender and age of children and educational level, occupational rank, and marital status of parents or legal guardians), lifestyles (physical and dietary patterns) and anthropometric data collected by qualified personnel (weight and height).

2.2. DNA Isolation and Genotyping Assays

For genotyping, DNA was extracted from buccal swabs using a procedure based on proteinase K digestion and saline purification. DNA quantification was performed using the QubitTM 4.0 fluorometer (InvitrogenTM by ThermoFisher Scientific, Waltham, MA, USA) with the Qubit dsDNA BR Assay Kit (InvitrogenTM by ThermoFisher Scientific, Hillsboro, OR, USA). DNA samples were frozen at −20 °C until the genotyping step.
Ten SNPs were selected based on two selection criteria: (1) a minor allele frequency (MAF) higher than 10% within the Iberian population and (2) a greater number of studies on the association with neurodevelopmental functions in healthy and clinical populations. These SNPs are in genes involved in brain development and synaptic plasticity (BDNF rs6265 and rs11030101; neurotrophic receptor tyrosine kinase 2 (NTRK2) rs2289656 and rs10868235; methylenetetrahydrofolate reductase (MTHFR) rs1801133; and synaptosome associated protein 25 (SNAP25) rs363039) and neurotransmitter systems (5-hydroxytryptamine receptor 2A (HTR2A) rs6314 and rs7997012; oxytocin receptor (OXTR) rs53576; and solute carrier family 6 member 2 (SLC6A2) rs998424).
Information on the gene, chromosomal location, variant effect, genotype, and allele frequencies were obtained from Ensembl “https://www.ensembl.org/index.html (accessed on 22 January 2024)”and The National Centre for Biotechnology Information SNP website “https://www.ncbi.nlm.nih.gov/ (accessed on 22 January 2024)”, and are listed in Table 1.
Two types of genotyping technologies were performed: (1) Infinium Global Screening Array (GSA)-24 BeadChip and (2) Taqman SNP Genotyping Assays. In the first place, 7 SNPs were genotyped using the microarray technology on the iScan system by Ilumina® Infinium® HTS Assay (Illumina, Inc., San Diego, CA, USA) according to the method previously described by Ramírez et al. (2023) [19]. GSA data were read and analysed with the software llumina® GenomeStudio v2010.3.
In Taqman assays, 3 SNPs were genotyped by the following commercially available Taqman® probes (Applied Biosystems™ Taqman SNP Genotyping Assays): C___1751785_10 for BDNF rs11030101, C___3020067_10 for SLC6A2 rs998424, and C____327976_10 for SNAP25 rs363039. Quantitative PCRs (qPCRs) were performed on the QuantStudio™ 6 Flex Real-Time PCR System (Applied Biosystems™, Waltham, MA, USA) and data outputs were read and processed with the software QuantStudio™ Real-Time PCR v1.3.1 [20].
Those SNPs presenting a call rate of less than 95% that deviated from Hardy–Weinberg equilibrium (HWE, p < 0.05) and samples with an overall call rate of less than 95% were excluded from the final statistical analysis.

2.3. Bisphenol Exposure Assessment

Daily dietary exposure to total bisphenols (BPA plus BPS) was estimated on an individual basis by multiplying the daily intake of different foods (g/day) by the corresponding bisphenol content in each food item (ng/g of food). The dietary information was recorded for the last 12 months through a semi-quantitative food frequency questionnaire (FFQ). This food survey was designed to ask about the food frequency (g of food per day) of 112 food items categorised into 13 groups, e.g., dairy products, meat and meat products, vegetables, legumes, and cereals, among others [21]. After that, the bisphenol content was chemically determined via an ultra-high performance liquid chromatography–tandem mass spectrometry (UHPLC-MS/MS) system following the methodology described by Galvez-Ontiveros et al. (2021) [22]. Finally, BPA intake from all food sources analysed was summed for all individuals to estimate the total exposure dose (ng/day).

2.4. Neurodevelopmental Assessment

Cognitive functions in children aged 6–12 years were assessed using the Spanish form of the Weschler Intelligence Scale for Children—Fifth Edition (WISC-V), administrated by licensed and trained psychologists in childhood neurodevelopment. The WISC-V assesses various cognitive domains, providing a comprehensive profile of a child’s cognitive abilities. The test is composed of 10 primary subtests, which can be combined into composite quotients, yielding five age-standardised primary indices: Verbal Comprehension Index (VCI), Visual Spatial Index (VSI), Fluid Reasoning Index (FRI), Working Memory Index (WMI), and Processing Spead Index (PSI). The Full-Scale Intelligence Quotient (FSIQ) is derived from seven primary subtests, typically Similarities, Vocabulary, Block Design, Matrix Reasoning, Figure Weights, Digit Span, and Coding.
For this study, the five primary indices and FSIQ scores (mean = 100, standard deviation (SD) = 15) were selected to address the cognitive profiles and IQ.

2.5. Data Analysis

Descriptive analyses of quantitative variables were carried out using the means and SDs for parametric variables, and medians and interquartile ranges (IQRs) in the case of non-parametric variables. The qualitative variables are presented in terms of frequencies and percentages. The Kolmogorov–Smirnov test with Lilliefors correction was performed to check the normality of continuous data.
To assess Hardy–Weinberg equilibrium (HWE), chi-square tests were applied (p > 0.05) in the codominant model. Linkage disequilibrium (LD) analyses were performed using SNPStats software “https://snpstats.net/start.htm (accessed on 10 February 2024)”. SNPs were in LD when they had an r2 value higher than 0.5. After verifying HWE and LD, the analyses were undertaken within the dominant or recessive model, and the contribution per allele was tested.
Student’s t-test and the Mann–Whitney test were conducted for parametric and non-parametric variables, respectively. They were used to compare WISC-V index scores for each different genetic variant.
Crude odds ratios (ORs) and 95% confidence intervals (95% CIs) were calculated using binary logistic regression models to evaluate the influence of the genetic variants on WISC-V index scores. The WISC-V index was entered as the dependent variable, each genetic polymorphism as the independent variable, and dietary exposure to bisphenols (stratified by low and high exposure according to median values expressed as ng/day) was input as the selecting variable. Multivariable logistic regression models were then fitted that included sex, age, body mass index (BMI), and/or parental education level as potential confounders of neurological testing [23,24]. Sex and age were used as confounding factors in all analyses, and BMI and parental education level were included in the model if they produced changes in the OR of more than 10%. To explore gene–environment interactions in cognitive functions, the interaction term “polymorphism x exposure level” was added to the logistic regressions. Statistical significance was based on a p value ≤ 0.05. In addition, Bonferroni’s correction was applied to the multifactorial logistic regression p values to account for the multiple testing of 10 different SNPs (p ≤ 0.005). All statistical analyses were performed with IBM SPSS Statistics 25 (Armonk, NY, USA) and RStudio 2023.12.0.

3. Results

3.1. Characteristics of Participants

Baseline characteristics of the study population are shown in Table 2. Of the 102 children included, 53 (52%) were boys and the mean age was 8.7 ± 2.1 years. The estimated daily dietary exposure dose for total bisphenols was 17306.3 ng/day. The educational level of the parents was classified into primary, secondary, and university education, with most of parents belonging to university category (50%). Regarding overall cognitive performance, the mean of the WISC-V FSIQ was 101.1 (12.7).

3.2. Genetic Variants and WISC-V Scores

All SNPs achieved HWE (p > 0.05, Table 1). The MAFs of each locus were in agreement with those established for the Iberian population; only for NTRK2 rs10868235 G/A was the variant A allele the minor allele in our cohort instead of the previously reported reference G allele. Those SNPs within the same gene were not in LD (BDNF rs6265/rs11030101 r2 = 0.17; HTR2A rs6314/rs7997012 r2 = 0.06; and NTRK2 rs2289656/rs10868235 r2 = 0.04).
Table 3 shows in detail the mean and median values of the WISC-V index scores obtained for each genetic variant. For the first BDNF rs6265/rs11030101 variant pair, opposite effects were found. Children with BDNF rs6265 AG/AA genotypes had significantly lower FRI scores than those homozygous for the reference G allele (p = 0.030). On the contrary, children who carried one or two copies of the rs11030101 minor T allele displayed significantly higher FRI (p = 0.009) scores than children who showed the wild AA genotype, suggesting a protective effect.
This protective trend was maintained for other genetic variants. For example, children inheriting at least one copy of the variant allele of MTHFR rs1801133 G/A and SNAP25 rs363039 G/A obtained better scores on the visual spatial (p = 0.038 for rs1801133), verbal comprehension, and fluid reasoning domains (p = 0.026 and p = 0.004 for rs363039, respectively).
Looking at these results, more significant differences in fluid reasoning scores were observed under the dominant model of BDNF rs6265/rs11030101 and SNAP25 rs363039 variants (Figure 1).

3.3. Influence of Genetic Variants on the Cognitive Profile Assessed by WISC-V According to Dietary Exposure to Bisphenols

Here, the contribution of each genetic variant to possible changes in cognitive function was addressed by dividing the population into groups with low and high exposure to bisphenols. When the dietary exposure factor was entered, highly significant associations between genetic polymorphisms and WISC-V indices were obtained, which were even stronger after adjustment for sex, age, BMI, and/or parental education levels as covariates. The SNP-by-bisphenol exposure interaction was also explored to verify if the effect of the variant depended on the magnitude of exposure. Table 4 shows only the significant outcomes; the rest of the results are fully described in the Supplementary Material (Table S1).
Focusing on SNP pairs for BDNF and its receptor NTRK2, the BDNF rs11030101 variant T allele conferred protection against verbal comprehension dysfunction (adjusted OR = 0.26, p = 0.011, p interaction = 0.067).
NTRK2 SNPs showed a dual effect, where the rs2289656 G/A polymorphism proved to be a risk variant (adjusted OR = 6.72, p = 0.004, p interaction = 0.062 for VCI), whereas rs10868235 developed a protective function in two cognitive aspects (adjusted OR = 0.22, p = 0.062, p interaction = 0.043 for VCI; and adjusted OR = 0.18, p = 0.034, p interaction = 0.020 for VSI), and the interaction was significant.
With regards to the serotonin signalling pathway, two variants within the HTR2A gene were explored and, once again, opposite associations were observed. The rs6314 G/A polymorphism seemed to confer a protective effect on poorer verbal comprehension at low exposure (adjusted OR = 0.15, p = 0.042, p interaction = 0.820) In contrast, the rs7997012 A/G effect differed based on the exposure degree: a significant decline in working memory was appreciated at low exposure levels (adjusted OR = 6.30, p = 0.017), whereas a modest improvement was observed at high levels (adjusted OR = 0.27, p = 0.096). After Bonferroni’s correction, strong interaction evidence (p interaction = 0.002) resulted from this differential effect.
For the MTHFR rs1801133 G/A polymorphism in the per-allele contribution model, the presence of the variant A allele was associated with a reduced likelihood of cognitive dysfunctions than the presence of the reference G allele at a low exposure dose (adjusted OR = 0.28, p = 0.010, p interaction = 0.026 for WMI; and adjusted OR = 0.36, p = 0.030, p interaction = 0.025 for FSIQ).
Lastly, a protective role was observed for the genetic variants OXTR rs53576 A/G (adjusted OR = 0.08, p = 0.007, p interaction = 0.030 for WMI) and SLC6A2 rs998424 G/A (adjusted OR = 0.16, p = 0.005, p interaction = 0.004 for FRI) in terms of high exposure. After Bonferroni’s correction, the association and interaction persisted for SLC6A2 rs998424. Other genetic variants, such as SNAP25 rs363039 G/A, maintained their remarkable protective function independently of the exposure, resulting in a non-significant interaction (p interaction of 0.258, 0.775, and 0.378 for FRI, WMI and FSIQ, respectively).
Figure 2 highlights the associations and interactions obtained mainly for the verbal comprehension, working memory, and fluid reasoning domains.

4. Discussion

As far we know, our findings suggest for the first time that neurodevelopment-related gene polymorphisms play an important role in cognition measured through WISC-V in Spanish children exposed to dietary bisphenols. The main outcomes of the current research included the following aspects: (1) significant differences in fluid reasoning scores were observed mainly for BDNF rs6265/rs11030101 and SNAP25 rs363039 variants, and (2) consistent associations of BDNF rs11030101, NTRK2 rs2289656/rs10868235, MTHFR rs1801133, HTR2A rs7997012, OXTR rs53576, and SLC6A2 rs998424 with certain cognitive domains and global intelligence index were obtained in the presence of bisphenol exposure, resulting in relevant SNP–bisphenol interactions.
Gene polymorphisms selected for this study are located in genes responsible for key neurodevelopmental processes, and it is well known that NDDs such as ADHD, ASD, and ID are genetically linked through common genetic alterations [6].
BDNF and its receptor tropomyosin receptor kinase B (TrkB), encoded by the NTRK2 gene, are an essential regulatory system for neuronal development, synaptogenesis, and plasticity [25]. The possible involvement of BDNF in cognitive dysfunction was observed in children with ID showing reduced BDNF protein levels [26]. Furthermore, it has been evidenced that BDNF and NTRK2 variants are associated with changes in hippocampal volume and altered performance on learning and memory tasks [25,27]. BDNF rs6265 (Val66Met) is one of the most extensively studied missense variants within the prodomain region of BDNF, with functional consequences for memory, cognition, and behaviour [12].
In our study, rs6265 variant A allele carriers had lower scores on the fluid reasoning domain, whereas children with the rs11030101 T allele experienced a better scenario for this cognitive component. These polymorphisms have been reported to be associated with other psychiatric and neurological disorders like major depressive disorder (MDD) [28,29], schizophrenia, or epilepsy [30]. However, no associations were found with cognitive outcomes [31,32].
Our gene–environment association analysis revealed interactions between variants in the BDNF-NTRK2 system, such as rs10868235, and exposure to bisphenols in the context of verbal comprehension and visual spatial skills. Although there are no studies assessing interactions between these SNPs and dietary contaminants in neurodevelopment, some evidence suggests that BPA may interfere with the BDNF signalling pathway, leading to behavioural and cognitive impairments [33,34].
Like the BDNF-NTRK2 system, MTHFR and SNAP25 are involved in brain development and synaptic plasticity, respectively [35,36]. Firstly, proper folate metabolism is required for normal brain development, and so disruptions in this process may contribute to neurological disorders [35]. MTHFR is a key folate metabolism enzyme, whose deficiency has been correlated with common variants like rs1801133 (C677T) and rs1801131 (A1298C) [37]. We found that the presence of the variant A allele of the rs1801133 G/A polymorphism was linked to higher scores for working memory and FSIQ at a low bisphenol exposure dose (Table 4). This finding makes sense given the peculiar U-shaped dose–response curve followed by bisphenols, indicating the importance of investigating effects at both low and high exposure levels. In line with our result, the rs1801133 A allele was also found to attenuate the negative effect of COMT Val homozygosity on IQ in patients with schizophrenia [38]. A meta-analysis by Sun et al. (2021) did not find associations between this MTHFR SNP and mild cognitive impairment [39]. At the level of gene–environment interactions, possible connections of bisphenols with disrupted MTHFR metabolic functions have not yet been established.
For its part, the SNAP25 gene is involved in synaptic plasticity, neuronal maturation, and neurotransmission [36]. In children with borderline intellectual functioning, SNAP25 polymorphisms were associated with lower scores for the perceptual reasoning index and FSIQ [36]. In the present child population, the SNAP25 rs363039 G/A variant maintained its protective function in fluid reasoning, working memory, and overall IQ, independent of the exposure. In agreement with this finding, the A allele of rs363039 was reported to be beneficial for working memory in individuals with ADHD [40].
On the other hand, we have also focused on genetic changes at the level of neurotransmitter systems (HTR2A, OXTR, and SLC6A2). The serotonin 2A receptor, encoded by the HTR2A gene, is located in brain regions essential for learning and cognition. In fact, polymorphisms within this gene, such the rs6314 (His452Tyr), have been associated with altered memory processes [41]. Consistent with this, we found that the HTR2A rs7997012 A/G variant was related to altered working memory at low bisphenol exposure, whereas the opposite effect was modestly observed at high levels, resulting in a strong interaction. This finding shed light that genetics interact with a dynamic environment, leading to differential effects depending on the exposure level. Conversely, the other variant, HTR2A rs6314, maintained its protective role against poorer verbal comprehension independent of the exposure level. Until now, evidence from animal studies has demonstrated that mixtures of EDCs, including BPA, could impair mouse behaviour by modifying the brain expression of Htr1a and Htr2a [42].
Another variant that showed a protective effect on working memory was the OXTR rs53576 A/G polymorphism in children with high bisphenol levels. This polymorphism is located in the gene encoding the receptor for oxytocin, a neuromodulator involved in forming social, working, spatial, and episodic memory [43]. OXTR rs53576 has been proven to be associated with poorer social cognition in children but also with protective social traits, such as prosocial and empathic behaviour [44,45,46]. Meanwhile, the OXTR rs53576–bisphenol interaction found in our study could make sense from in vivo studies. Here, perinatal exposure to BPA, alone or in a mixture, alters oxytocin and OXTR expression in a sex- and region-specific manner [42,47].
Finally, OXTR rs53576 also showed protection for fluid reasoning, but the interaction was not significant. However, a strong interaction was obtained for the SLC6A2 rs998424 G/A variant. Polymorphic variants in this gene coding for the norepinephrine transporter have been implicated in ADHD-related impairments, such as altered intrinsic brain activity, visual memory, and attention in children [48,49,50]. As aforementioned, BPA exposure may affect the serotonergic and oxytocin systems in the brain, but the effects on the norepinephrine system remain unclear.
One limitation of our study was the sample size. Although this is a limitation of several genetic association studies [36,45,51], the insightful findings of our small-scale study highlight the value of further larger studies to replicate and validate the results. It is well established that adverse neurodevelopmental effects of bisphenols are more pronounced in early age [13]. To date, evidence of the effects of childhood BPA exposure on cognitive function remain inconclusive [15,16]. One study addressed associations of urinary BPA concentrations with WISC-IV scores at different ages [15], while another study used age as an adjusting variable [16]. Given the limited sample size, it was not possible to perform an age-stratified analysis, but the regression models were adjusted for age to minimise potential confounding effects.
An additional limitation is that the particular effect of each SNP varies depending on which allele is designated as the “risk” allele. This is the reason why contradictory results can be obtained between different studies for the same genetic variant. Furthermore, the study design (neurodevelopment assessment tool, ethnic heterogeneity, and selected study population) could explain the inconsistencies between studies. There are several non-dietary sources of human exposure to bisphenols, which were not considered for the purpose of this study; however, the largest contribution to total exposure comes from food intake, accounting for more than 90%, confirming that a dietary exposure assessment is the first step in addressing the bisphenol-associated health problems [52].
The main strength of the current study lies in providing insightful evidence on the influence of genetic polymorphisms on childhood cognitive function in the presence of exposure to bisphenols. Firstly, carriers of the BDNF rs11030101 T and SNAP25 rs363039 A alleles obtained better scores on the fluid reasoning domain, except for those inheriting the BDNF rs6265 A allele, who had lower scores. In comparison with previous WISC versions, in WISC-V, the perceptual reasoning domain is divided into FRI and VSI, and the fluid reasoning domain could be a good indicator of intellectual functioning, as we have shown [53].
Secondly, we reported relevant SNP–bisphenol interactions in certain cognitive domains. Genetic variants in genes responsible for vital neurodevelopmental processes, such as brain development and synaptic plasticity (BDNF rs11030101, NTRK2 rs2289656 and rs10868235, and MTHFR rs1801133) and neurotransmission (HTR2A rs7997012, OXTR rs53576, and SLC6A2 rs998424) presented consistent associations with verbal comprehension, working memory, and fluid reasoning. The effects on these cognitive abilities depended on the level of exposure to bisphenol. Two aspects need to be highlighted here. (1) Genetics interact with an environment that is constantly changing, and for this reason the study of gene–environment interaction gives us a more complete answer to disease aetiology [54]; (2) EDCs, including bisphenols, follow a particular dose–response curve, with optimal effects at low doses, and so it is important to assess effects at low concentrations [55]. Additionally, (3) working memory is a cognitive domain involved in many aspects of neurodevelopment, and given the significance found in this area, we support considering the selected SNPs as genetic markers of cognitive alterations in individuals with NDDs. Similarly, the Weschler Intelligence Scales are the most widely used instruments for measuring cognitive function, and the latest version, the WISC-V, has undergone changes that may make it more reliable for assessing cognitive dysfunction in the etiopathogenesis of NDDs [53,56].

5. Conclusions

In conclusion, our findings demonstrate that SNPs related to brain development, synaptic plasticity, and neurotransmission are associated with differences in cognitive domains assessed by WISC-V, specifically fluid reasoning, verbal comprehension and working memory, in children exposed to bisphenols, revealing important SNP–bisphenol interactions. The exploration of gene–environment interactions could lead to a better understanding of the multifactorial and polygenetic aetiology of NDDs. For this reason, and in view of the lack of studies assessing the combined effects of genetic variability and exposure to bisphenols on cognitive function, we support considering them as interactive factors rather than individual contributors to NDDs.

Supplementary Materials

The following supporting information can be downloaded at https://www.mdpi.com/article/10.3390/nu16162639/s1, Table S1. Influence of genetic polymorphisms on the cognitive profile of children assessed by WISC-V according to bisphenol exposure.

Author Contributions

Conceptualization, C.M. and A.R.; methodology, V.R. and P.G.-P.; formal analysis, V.R. and C.M.; investigation, V.R.; data curation, V.R., P.G.-P. and C.M.; writing—original draft preparation, V.R.; writing—review and editing, P.J.G.-D., S.J.-P., L.R., M.J.Á.-C., C.M., L.J.M.-G. and A.R.; visualization, V.R.; supervision, P.J.G.-D., M.A.B., M.J.Á.-C., C.M., L.J.M.-G. and A.R.; project administration, A.R.; funding acquisition, A.R. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by Instituto de Salud Carlos III (ISCIII) through the project “PI23/01359” and co-funded by the European Union.

Institutional Review Board Statement

The study protocol was approved by the Ethics Committee of Provincial Biomedical Research of Granada (1742-N-23). Date: 31 January 2024.

Informed Consent Statement

Written informed consent was obtained from the parents or legal tutors of children.

Data Availability Statement

Data are contained within the article.

Acknowledgments

The results presented in this article are part of a doctoral thesis by Viviana Ramírez, Nutrition and Food Sciences Doctorate Program of the University of Granada.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Morris-Rosendahl, D.J.; Crocq, M. Neurodevelopmental disorders-the history and future of a diagnostic concept. Dialogues Clin. Neurosci. 2020, 22, 65–72. [Google Scholar] [CrossRef]
  2. Parenti, I.; Rabaneda, L.G.; Schoen, H.; Novarino, G. Neurodevelopmental Disorders: From Genetics to Functional Pathways. Trends Neurosci. 2020, 43, 608–621. [Google Scholar] [CrossRef]
  3. Braun, J.M. Early-life exposure to EDCs: Role in childhood obesity and neurodevelopment. Nat. Rev. Endocrinol. 2017, 13, 161–173. [Google Scholar] [CrossRef] [PubMed]
  4. Hiraide, T.; Yamoto, K.; Masunaga, Y.; Asahina, M.; Endoh, Y.; Ohkubo, Y.; Matsubayashi, T.; Tsurui, S.; Yamada, H.; Yanagi, K.; et al. Genetic and phenotypic analysis of 101 patients with developmental delay or intellectual disability using whole-exome sequencing. Clin. Genet. 2021, 100, 40–50. [Google Scholar] [CrossRef]
  5. Maulik, P.K.; Mascarenhas, M.N.; Mathers, C.D.; Dua, T.; Saxena, S. Prevalence of Intellectual Disability: A Meta-Analysis of Population-Based Studies. Res. Dev. Disabil. 2011, 32, 419–436. [Google Scholar] [CrossRef]
  6. Totsika, V.; Liew, A.; Absoud, M.; Adnams, C.; Emerson, E. Mental health problems in children with intellectual disability. Lancet Child Adolesc. Health. 2022, 6, 432–444. [Google Scholar] [CrossRef]
  7. Leblond, C.S.; Le, T.; Malesys, S.; Cliquet, F.; Tabet, A.; Delorme, R.; Rolland, T.; Bourgeron, T. Operative list of genes associated with autism and neurodevelopmental disorders based on database review. Mol. Cell Neurosci. 2021, 113, 103623. [Google Scholar] [CrossRef]
  8. Stefanski, A.; Calle-López, Y.; Leu, C.; Pérez-Palma, E.; Pestana-Knight, E.; Lal, D. Clinical sequencing yield in epilepsy, autism spectrum disorder, and intellectual disability: A systematic review and meta-analysis. Epilepsia 2021, 62, 143–151. [Google Scholar] [CrossRef] [PubMed]
  9. Chen, J.; Yu, W.; Tsai, M.; Hung, P.; Tu, Y. Comorbidities associated with genetic abnormalities in children with intellectual disability. Sci. Rep. 2021, 11, 6563. [Google Scholar] [CrossRef]
  10. Ramírez, V.; González-Palacios, P.; Baca, M.A.; González-Domenech, P.J.; Fernández-Cabezas, M.; Álvarez-Cubero, M.J.; Rodrigo, L.; Rivas, A. Effect of exposure to endocrine disrupting chemicals in obesity and neurodevelopment: The genetic and microbiota link. Sci. Total Environ. 2022, 852, 158219. [Google Scholar] [CrossRef]
  11. Bass, N.; Skuse, D. Genetic testing in children and adolescents with intellectual disability. Curr. Opin. Psychiatry 2018, 31, 490–495. [Google Scholar] [CrossRef] [PubMed]
  12. Szarowicz, C.A.; Steece-Collier, K.; Caulfield, M.E. New Frontiers in Neurodegeneration and Regeneration Associated with Brain-Derived Neurotrophic Factor and the rs6265 Single Nucleotide Polymorphism. Int. J. Mol. Sci. 2022, 23, 8011. [Google Scholar] [CrossRef] [PubMed]
  13. Ramírez, V.; Gálvez-Ontiveros, Y.; González-Domenech, P.J.; Baca, M.Á.; Rodrigo, L.; Rivas, A. Role of endocrine disrupting chemicals in children’s neurodevelopment. Environ. Res. 2022, 203, 111890. [Google Scholar] [CrossRef] [PubMed]
  14. EFSA Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids; Lambré, C.; Barat Baviera, J.M.; Bolognesi, C.; Chesson, A.; Cocconcelli, P.S.; Crebelli, R.; Gott, D.M.; Grob, K.; Lampi, E.; et al. Re-evaluation of the risks to public health related to the presence of bisphenol A (BPA) in foodstuffs. EFSA J. 2023, 21, e06857. [Google Scholar] [PubMed]
  15. Stacy, S.L.; Papandonatos, G.D.; Calafat, A.M.; Chen, A.; Yolton, K.; Lanphear, B.P.; Braun, J.M. Early life bisphenol A exposure and neurobehavior at 8years of age: Identifying windows of heightened vulnerability. Environ. Int. 2017, 107, 258–265. [Google Scholar] [CrossRef] [PubMed]
  16. Rodriguez-Carrillo, A.; Mustieles, V.; Perez-Lobato, R.; Molina-Molina, J.M.; Reina-Perez, I.; Vela-Soria, F.; Rubio, S.; Olea, N.; Fernandez, M.F. Bisphenol A and cognitive function in school-age boys: Is BPA predominantly related to behavior? Neurotoxicology 2019, 74, 162–171. [Google Scholar] [CrossRef] [PubMed]
  17. Santos, J.X.; Rasga, C.; Marques, A.R.; Martiniano, H.; Asif, M.; Vilela, J.; Oliveira, G.; Sousa, L.; Nunes, A.; Vicente, A.M. A Role for Gene-Environment Interactions in Autism Spectrum Disorder Is Supported by Variants in Genes Regulating the Effects of Exposure to Xenobiotics. Front. Neurosci. 2022, 16, 862315. [Google Scholar] [CrossRef] [PubMed]
  18. Flores-Dorantes, M.T.; Diaz-Lopez, Y.E.; Gutierrez-Aguilar, R. Environment and Gene Association With Obesity and Their Impact on Neurodegenerative and Neurodevelopmental Diseases. Front. Neurosci. 2020, 14, 863. [Google Scholar] [CrossRef] [PubMed]
  19. Ramírez, V.; Salcedo-Bellido, I.; Rodrigo, L.; Hernández, F.G.; Olmedo, P.; Martínez-González, L.J.; Álvarez-Cubero, M.J.; Rivas, A. Association of genetic polymorphisms in detoxifying systems and urinary metal(loid) levels with excess body weight among Spanish children: A proof-of-concept study. Sci. Total Environ. 2023, 873, 162333. [Google Scholar] [CrossRef]
  20. Ramírez, V.; Robles-Aguilera, V.; Salcedo-Bellido, I.; Gálvez-Ontiveros, Y.; Rodrigo, L.; Martinez-Gonzalez, L.J.; Monteagudo, C.; Álvarez-Cubero, M.J.; Rivas, A. Effects of genetic polymorphisms in body mass index according to dietary exposure to bisphenols and parabens. Chemosphere 2022, 293, 133421. [Google Scholar] [CrossRef]
  21. Robles-Aguilera, V.; Gálvez-Ontiveros, Y.; Rodrigo, L.; Salcedo-Bellido, I.; Aguilera, M.; Zafra-Gómez, A.; Monteagudo, C.; Rivas, A. Factors Associated with Exposure to Dietary Bisphenols in Adolescents. Nutrients 2021, 13, 1553. [Google Scholar] [CrossRef] [PubMed]
  22. Gálvez-Ontiveros, Y.; Moscoso-Ruiz, I.; Rodrigo, L.; Aguilera, M.; Rivas, A.; Zafra-Gómez, A. Presence of Parabens and Bisphenols in Food Commonly Consumed in Spain. Foods 2021, 10, 92. [Google Scholar] [CrossRef] [PubMed]
  23. Julvez, J.; Davey Smith, G.; Ring, S.; Grandjean, P. A Birth Cohort Study on the Genetic Modification of the Association of Prenatal Methylmercury With Child Cognitive Development. Am. J. Epidemiol. 2019, 188, 1784–1793. [Google Scholar] [CrossRef] [PubMed]
  24. Wahlberg, K.E.; Guazzetti, S.; Pineda, D.; Larsson, S.C.; Fedrighi, C.; Cagna, G.; Zoni, S.; Placidi, D.; Wright, R.O.; Smith, D.R.; et al. Polymorphisms in Manganese Transporters SLC30A10 and SLC39A8 Are Associated With Children’s Neurodevelopment by Influencing Manganese Homeostasis. Front. Genet. 2018, 9, 664. [Google Scholar] [CrossRef] [PubMed]
  25. Sonoyama, T.; Stadler, L.K.; Zhu, M.; Keogh, J.M.; Henning, E.; Hisama, F.; Kirwan, P.; Jura, M.; Blaszczyk, B.K.; DeWitt, D.C.; et al. Human BDNF/TrkB variants impair hippocampal synaptogenesis and associate with neurobehavioural abnormalities. Sci. Rep. 2020, 10, 9028. [Google Scholar] [CrossRef] [PubMed]
  26. Esnafoglu, E.; Adıgüzel, Ö. Association of BDNF levels with IQ: Comparison of S100B and BDNF levels in typically developing children and subjects with neurologically normal nonsyndromic intellectual disability. J. Intellect. Disabil. Res. 2021, 65, 1073–1084. [Google Scholar] [CrossRef] [PubMed]
  27. Tomás, A.M.; Bento-Torres, N.V.O.; Jardim, N.Y.V.; Moraes, P.M.; da Costa, V.O.; Modesto, A.C.; Khayat, A.S.; Bento-Torres, J.; Picanço-Diniz, C.W. Risk Polymorphisms of FNDC5, BDNF, and NTRK2 and Poor Education Interact and Aggravate Age-Related Cognitive Decline. Int. J. Mol. Sci. 2023, 24, 17210. [Google Scholar] [CrossRef] [PubMed]
  28. Duan, Y.; Li, Y.; Yun, H.; Kaplan, A.M.; Kennedy, A.; Dong, Y.; He, S.C.; Zhang, X.Y. Interaction between the BDNF rs11030101 genotype and job stress on cognitive empathy. J. Affect. Disord. 2022, 308, 442–448. [Google Scholar] [CrossRef] [PubMed]
  29. Torres, C.M.; Siebert, M.; Bock, H.; Mota, S.M.; Castan, J.U.; Scornavacca, F.; de Castro, L.A.; Saraiva-Pereira, M.L.; Bianchin, M.M. Tyrosine receptor kinase B gene variants (NTRK2 variants) are associated with depressive disorders in temporal lobe epilepsy. Epilepsy Behav. 2017, 71, 65–72. [Google Scholar] [CrossRef]
  30. Suchanek-Raif, R.; Raif, P.; Kowalczyk, M.; Paul-Samojedny, M.; Zielińska, A.; Kucia, K.; Merk, W.; Kowalski, J. An Analysis of Five TrkB Gene Polymorphisms in Schizophrenia and the Interaction of Its Haplotype with rs6265 BDNF Gene Polymorphism. Dis. Markers 2020, 2020, 4789806. [Google Scholar] [CrossRef]
  31. Correa, D.D.; Satagopan, J.; Cheung, K.; Arora, A.K.; Kryza-Lacombe, M.; Xu, Y.; Karimi, S.; Lyo, J.; DeAngelis, L.M.; Orlow, I. COMT, BDNF, and DTNBP1 polymorphisms and cognitive functions in patients with brain tumors. Neuro-Oncology 2016, 18, 1425–1433. [Google Scholar] [CrossRef]
  32. Sanders, C.L.; Rattinger, G.B.; Deberard, M.S.; Hammond, A.G.; Wengreen, H.; Kauwe, J.S.; Buhusi, M.; Tschanz, J.T. Interaction Between Physical Activity and Genes Related to Neurotrophin Signaling in Late-Life Cognitive Performance: The Cache County Study. J. Gerontol. A Biol. Sci. Med. Sci. 2020, 75, 1633–1642. [Google Scholar] [CrossRef] [PubMed]
  33. Mustieles, V.; Rodríguez-Carrillo, A.; Vela-Soria, F.; d’Cruz, S.C.; David, A.; Smagulova, F.; Mundo-López, A.; Olivas-Martínez, A.; Reina-Pérez, I.; Olea, N. Fernández MF. BDNF as a potential mediator between childhood BPA exposure and behavioral function in adolescent boys from the INMA-Granada cohort. Sci. Total Environ. 2022, 803, 150014. [Google Scholar] [CrossRef] [PubMed]
  34. Hyun, S.A.; Ko, M.Y.; Jang, S.; Lee, B.S.; Rho, J.; Kim, K.K.; Kim, W.Y.; Ka, M. Bisphenol-A impairs synaptic formation and function by RGS4-mediated regulation of BDNF signaling in the cerebral cortex. Dis. Model Mech. 2022, 15, dmm049177. [Google Scholar] [CrossRef]
  35. Sadigurschi, N.; Scrift, G.; Hirrlinger, J.; Golan, H.M. Genetic impairment of folate metabolism regulates cortical interneurons and social behavior. Front. Neurosci. 2023, 17, 1203262. [Google Scholar] [CrossRef] [PubMed]
  36. Blasi, V.; Bolognesi, E.; Ricci, C.; Baglio, G.; Zanzottera, M.; Canevini, M.P.; Walder, M.; Cabinio, M.; Zanette, M.; Baglio, F.; et al. SNAP-25 Single Nucleotide Polymorphisms, Brain Morphology and Intelligence in Children With Borderline Intellectual Functioning: A Mediation Analysis. Front. Neurosci. 2021, 15, 715048. [Google Scholar] [CrossRef] [PubMed]
  37. Zhang, Y.X.; Yang, L.P.; Gai, C.; Cheng, C.C.; Guo, Z.Y.; Sun, H.M.; Hu, D. Association between variants of MTHFR genes and psychiatric disorders: A meta-analysis. Front. Psychiatry 2022, 13, 976428. [Google Scholar] [CrossRef] [PubMed]
  38. Murillo-García, N.; Barrio-Martínez, S.; Setién-Suero, E.; Soler, J.; Papiol, S.; Fatjó-Vilas, M.; Ayesa-Arriola, R. Overlap between genetic variants associated with schizophrenia spectrum disorders and intelligence quotient: A systematic review. J. Psychiatry Neurosci. 2022, 47, E393–E408. [Google Scholar] [CrossRef]
  39. Sun, J.; Jiang, X.; Zhao, M.; Ma, L.; Pei, H.; Liu, N.; Li, H. Association of Methylenetetrahydrofolate Reductase C677T Gene Polymorphisms with Mild Cognitive Impairment Susceptibility: A Systematic Review and Meta-Analysis. Behav. Neurol. 2021, 2021, 2962792. [Google Scholar] [CrossRef]
  40. Gao, Q.; Liu, L.; Chen, Y.; Li, H.; Yang, L.; Wang, Y.; Qian, Q. Synaptosome-related (SNARE) genes and their interactions contribute to the susceptibility and working memory of attention-deficit/hyperactivity disorder in males. Prog. Neuropsychopharmacol. Biol. Psychiatry 2015, 57, 132–139. [Google Scholar] [CrossRef]
  41. Zhang, G.; Stackman, R.W. The role of serotonin 5-HT2A receptors in memory and cognition. Front. Pharmacol. 2015, 6, 225. [Google Scholar] [CrossRef] [PubMed]
  42. Repouskou, A.; Papadopoulou, A.K.; Panagiotidou, E.; Trichas, P.; Lindh, C.; Bergman, Å.; Gennings, C.; Bornehag, C.G.; Rüegg, J.; Kitraki, E.; et al. Long term transcriptional and behavioral effects in mice developmentally exposed to a mixture of endocrine disruptors associated with delayed human neurodevelopment. Sci. Rep. 2020, 10, 9367. [Google Scholar] [CrossRef]
  43. Abramova, O.; Zorkina, Y.; Ushakova, V.; Zubkov, E.; Morozova, A.; Chekhonin, V. The role of oxytocin and vasopressin dysfunction in cognitive impairment and mental disorders. Neuropeptides 2020, 83, 102079. [Google Scholar] [CrossRef] [PubMed]
  44. Ríos, U.; Moran, J.; Hermosilla, J.; González, R.; Muñoz, P.; Arancibia, M.; Herrera, L.; Jiménez, J.P.; Moya, P.R. The interaction of the oxytocin receptor gene and child abuse subtypes on social cognition in euthymic patients with bipolar disorder type I. Front. Psychiatry 2023, 14, 1151397. [Google Scholar] [CrossRef] [PubMed]
  45. Slane, M.M.; Lusk, L.G.; Boomer, K.B.; Hare, A.E.; King, M.K.; Evans, D.W. Social cognition, face processing, and oxytocin receptor single nucleotide polymorphisms in typically developing children. Dev. Cogn. Neurosci. 2014, 9, 160–171. [Google Scholar] [CrossRef] [PubMed]
  46. Friedlander, E.; Yirmiya, N.; Laiba, E.; Harel-Gadassi, A.; Yaari, M.; Feldstein, O.; Mankuta, D.; Israel, S. Cumulative Risk of the Oxytocin Receptor Gene Interacts with Prenatal Exposure to Oxytocin Receptor Antagonist to Predict Children’s Social Communication Development. Autism Res. 2019, 12, 1087–1100. [Google Scholar] [CrossRef] [PubMed]
  47. Witchey, S.K.; Fuchs, J.; Patisaul, H.B. Perinatal bisphenol A (BPA) exposure alters brain oxytocin receptor (OTR) expression in a sex- and region- specific manner: A CLARITY-BPA consortium follow-up study. Neurotoxicology 2019, 74, 139–148. [Google Scholar] [CrossRef] [PubMed]
  48. Shang, C.; Lin, H.; Gau, S.S. The norepinephrine transporter gene modulates intrinsic brain activity, visual memory, and visual attention in children with attention-deficit/hyperactivity disorder. Mol. Psychiatry 2021, 26, 4026–4035. [Google Scholar] [CrossRef] [PubMed]
  49. Gomez-Sanchez, C.I.; Riveiro-Alvarez, R.; Soto-Insuga, V.; Rodrigo, M.; Tirado-Requero, P.; Mahillo-Fernandez, I.; Abad-Santos, F.; Carballo, J.J.; Dal-Ré, R.; Ayuso, C. Attention deficit hyperactivity disorder: Genetic association study in a cohort of Spanish children. Behav. Brain Funct. 2016, 12, 2. [Google Scholar] [CrossRef]
  50. Park, S.; Kim, J.W.; Yang, Y.H.; Hong, S.B.; Park, M.H.; Kim, B.N.; Shin, M.S.; Yoo, H.J.; Cho, S.C. Possible effect of norepinephrine transporter polymorphisms on methylphenidate-induced changes in neuropsychological function in attention-deficit hyperactivity disorder. Behav. Brain Funct. 2012, 8, 22. [Google Scholar] [CrossRef]
  51. Plaza-Florido, A.; Esteban-Cornejo, I.; Mora-Gonzalez, J.; Torres-Lopez, L.V.; Osuna-Prieto, F.J.; Gil-Cosano, J.J.; Radom-Aizik, S.; Labayen, I.; Ruiz, J.R.; Altmäe, S.; et al. Gene-exercise interaction on brain health in children with overweight/obesity: The ActiveBrains randomized controlled trial. J. Appl. Physiol. 2023, 135, 775–785. [Google Scholar] [CrossRef] [PubMed]
  52. Martínez, M.A.; Rovira, J.; Sharma, R.P.; Nadal, M.; Schuhmacher, M.; Kumar, V. Comparing dietary and non-dietary source contribution of BPA and DEHP to prenatal exposure: A Catalonia (Spain) case study. Environ. Res. 2018, 166, 25–34. [Google Scholar] [CrossRef] [PubMed]
  53. Audras-Torrent, L.; Miniarikova, E.; Couty, F.; Dellapiazza, F.; Berard, M.; Michelon, C.; Picot, M.C.; Baghdadli, A. WISC-V Profiles and Their Correlates in Children with Autism Spectrum Disorder without Intellectual Developmental Disorder: Report from the ELENA Cohort. Autism Res. 2021, 14, 997–1006. [Google Scholar] [CrossRef] [PubMed]
  54. Arango, C.; Dragioti, E.; Solmi, M.; Cortese, S.; Domschke, K.; Murray, R.M.; Jones, P.B.; Uher, R.; Carvalho, A.F.; Reichenberg, A.; et al. Risk and protective factors for mental disorders beyond genetics: An evidence-based atlas. World Psychiatry 2021, 20, 417–436. [Google Scholar] [CrossRef]
  55. Vandenberg, L.N.; Colborn, T.; Hayes, T.B.; Heindel, J.J.; Jacobs, D.R., Jr.; Lee, D.H.; Shioda, T.; Soto, A.M.; vom Saal, F.S.; Welshons, W.V.; et al. Hormones and endocrine-disrupting chemicals: Low-dose effects and nonmonotonic dose responses. Endocr. Rev. 2012, 33, 378–455. [Google Scholar] [CrossRef] [PubMed]
  56. Zabel, T.A.; Rao, R.; Jacobson, L.A.; Pritchard, A.E.; Mahone, E.M.; Kalb, L. An abbreviated WISC-5 model for identifying youth at risk for intellectual disability in a mixed clinical sample. Clin. Neuropsychol. 2022, 36, 626–638. [Google Scholar] [CrossRef]
Figure 1. Fluid reasoning index scores obtained for (A) BDNF rs6265, (B) BDNF rs11030101, and (C) SNAP25 rs363039.
Figure 1. Fluid reasoning index scores obtained for (A) BDNF rs6265, (B) BDNF rs11030101, and (C) SNAP25 rs363039.
Nutrients 16 02639 g001
Figure 2. Influence of genetic polymorphisms on specific cognitive domains based on the level of bisphenol exposure.
Figure 2. Influence of genetic polymorphisms on specific cognitive domains based on the level of bisphenol exposure.
Nutrients 16 02639 g002
Table 1. Information on the selected SNPs in the Spanish reference population (N = 107) and in our cohort (N = 102).
Table 1. Information on the selected SNPs in the Spanish reference population (N = 107) and in our cohort (N = 102).
Gene NameGene Functionrs IDChr Position (GRCh38/hg38)Reference/Variant AlleleVariant EffectMAF (N)
IBS aOur CohortHWE p Value b
BDNFNeuronal development, synaptogenesis, and plasticityrs6265 (Val66Met)chr11: 27658369C/T or G/AMissense variantT: 0.210 (45)A: 0.211 (43)0.132
BDNFrs11030101chr11: 27659197A/T5 prime UTR variantT: 0.435 (93)T: 0.392 (80)0.264
HTR2ALearning and cognitive abilitiesrs6314 (His452Tyr)chr13: 46834899G/AMissense variantA: 0.107 (23)A: 0.103 (21)0.324
HTR2Ars7997012chr13: 46837850A/GIntron variantA: 0.388 (83)A: 0.333 (68)0.766
MTHFRBrain development and synaptic plasticityrs1801133 (C677T)chr1: 11796321G/AMissense variantA: 0.444 (95)A: 0.377 (77)0.823
OXTRSocial, working, spatial, and episodic memory formationrs53576chr3: 8762685A/GIntron variantA: 0.308 (66)A: 0.294 (60)0.384
SLC6A2Mood, attention, and stress response regulationrs998424chr16: 55698034G/AIntron variantA: 0.308 (66)A: 0.377 (77)0.536
SNAP25Brain development and synaptic plasticityrs363039chr20: 10239848G/AIntron variantA: 0.383 (82)A: 0.328 (67)0.653
NTRK2Neuronal development, synaptogenesis, and plasticityrs2289656chr9: 84948647G/AIntron variantA: 0.206 (44)A: 0.181 (37)0.273
NTRK2rs10868235chr9: 84878840C/T or G/AIntron variantC: 0.486 (104)A: 0.480 (98)0.831
MAF: minor allele frequency. a IBS: Iberian population MAF values from the Ensembl database “https://www.ensembl.org/index.html (accessed on 22 January 2024)”. b HWE: Hardy–Weinberg equilibrium by the chi-square test.
Table 2. General characteristics of the study population (N = 102).
Table 2. General characteristics of the study population (N = 102).
Age in years, mean (SD)8.7 (2.1)
Gender, n (%)
  Boys53 (52.0)
  Girls49 (48.0)
Weight in kg, mean (SD)36.9 (15.0)
Height in cm, mean (SD)134.8 (18.8)
BMI in kg/m2, mean (SD)19.3 (4.9)
Bisphenols in ng/day, median (IQR)17306.3 (9674.2–27067.7)
  Bisphenol A6823.7 (3575.9–12305.9)
  Bisphenol S6976.4 (3459.9–17472.7)
Parental education level, n (%)
  Up to primary12 (11.8)
  Secondary38 (37.3)
  University51 (50.0)
  Missing data1 (0.9)
WISC-V indices
  Verbal Comprehension Index (VCI), median (IQR)106.0 (95.0–113.0)
  Visual Spatial Index (VSI), mean (SD)102.5 (15.3)
  Fluid Reasoning Index (FRI), median (IQR)106.0 (94.0–115.0)
  Working Memory Index (WMI), mean (SD)101.9 (14.2)
  Processing Spead Index (PSI), median (IQR)86.0 (77.0–92.0)
  Full-Scale Intelligence Quotient (FSIQ), mean (SD)101.1 (12.7)
SD: standard deviation; BMI: body mass index; IQR: interquartile range; bw: body weight.
Table 3. Scoring of each WISC-V index by genetic variant.
Table 3. Scoring of each WISC-V index by genetic variant.
VCI aVSI bFRI aWMI bPSI aFSIQ b
NMedian (IQR)p ValueMean (SD)p ValueMedian (IQR)p ValueMean (SD)p ValueMedian (IQR)p ValueMean (SD)p Value
BDNF rs6265 (Dom)
GG61108.0 (95.0–116.0)0.444102.6 (12.9)0.920106.0 (95.5–115.0)0.030101.3 (14.7)0.60583.0 (76.0–92.0)0.251102.1 (12.0)0.338
AG + AA41106.0 (95.0–111.0) 102.3 (18.5) 100.0 (88.0–112.0) 102.8 (13.6) 89.0 (80.0–95.0) 99.6 (13.6)
G161106.0 (95.0–114.5)0.520102.5 (14.5)0.967106.0 (94.0–115.0)0.069101.6 (14.4)0.57286.0 (77.0–92.0)0.278101.4 (12.4)0.476
A43106.0 (95.0–111.0) 102.4 (18.3) 100.0 (88.0–112.0) 103.0 (13.5) 89.0 (80.0–95.0) 99.9 (13.6)
BDNF rs11030101 (Dom)
AA35103.0 (92.0–113.0)0.119100.5 (13.5)0.35594.0 (91.0–109.0)0.009101.4 (13.1)0.80586.0 (77.0–95.0)0.75397.8 (11.5)0.056
AT + TT67108.0 (98.0–118.0) 103.5 (16.2) 106.0 (97.0–118.0) 102.2 (14.8) 83.0 (77.0–92.0) 102.8 (13.0)
A124106.0 (95.0–113.0)0.261101.5 (14.8)0.277103.0 (91.0–112.0)0.014101.7 (13.7)0.80886.0 (77.8–95.0)0.40499.9 (12.5)0.101
T80108.0 (95.8–118.0) 103.9 (16.1) 106.0 (97.0–117.3) 102.2 (15.0) 83.0 (77.0–92.0) 102.9 (12.6)
HTR2A rs6314 (Dom)
GG83103.0 (95.0–113.0)0.117102.4 (15.4)0.960106.0 (91.0–115.0)0.433102.4 (14.4)0.50786.0 (77.0–92.0)0.812100.6 (13.0)0.425
AG + AA19111.0 (100.0–118.0) 102.6 (15.4) 106.0 (97.0–115.0) 99.9 (13.6) 83.0 (77.0–95.0) 103.2 (11.1)
G183106.0 (95.0–113.0)0.109102.5 (15.4)0.942106.0 (94.0–115.0)0.443102.1 (14.3)0.53686.0 (77.0–92.0)0.799100.8 (12.8)0.385
A21111.0 (103.0–115.5) 102.2 (15.2) 106.0 (98.5–113.5) 100.1 (13.3) 89.0 (77.0–95.0) 103.4 (10.7)
HTR2A rs7997012 (Rec)
AA + AG56108.0 (95.0–116.0)0.718103.9 (16.0)0.310106.0 (94.0–115.0)0.167102.3 (14.4)0.73983.0 (77.8–92.0)0.741102.0 (13.0)0.426
GG46104.5 (98.0–113.0) 100.8 (14.5) 106.0 (91.0–112.0) 101.4 (14.1) 86.0 (77.0–95.0) 100.0 (12.3)
A68108.0 (95.0–115.3)0.734104.6 (16.2)0.160106.0 (94.0–115.0)0.202101.9 (14.1)0.99283.0 (77.0–92.0)0.858102.7 (12.8)0.215
G136106.0 (95.0–113.0) 101.4 (14.8) 106.0 (91.0–112.0) 101.9 (14.3) 86.0 (77.0–92.0) 100.3 (12.5)
MTHFR rs1801133 (Dom)
GG39106.0 (95.0–111.0)0.21898.5 (14.5)0.038103.0 (91.0–115.0)0.177100.4 (14.5)0.38886.0 (80.0–92.0)0.35498.4 (12.5)0.087
AG + AA63108.0 (95.0–116.0) 104.9 (15.4) 106.0 (97.0–115.0) 102.9 (14.0) 83.0 (77.0–92.0) 102.8 (12.6)
G127106.0 (95.0–113.0)0.462100.9 (15.5)0.061103.0 (91.0–115.0)0.214101.0 (14.4)0.24386.0 (77.0–92.0)0.634100.0 (12.8)0.060
A77108.0 (95.0–116.0) 105.1 (14.7) 106.0 (97.0–113.5) 103.4 (13.7) 83.0 (77.0–93.5) 102.9 (12.3)
OXTR rs53576 (Rec)
AA + AG53103.0 (95.0–113.0)0.283103.0 (15.0)0.709103.0 (91.0–110.5)0.078100.8 (13.8)0.43583.0 (77.0–92.0)0.94199.6 (13.4)0.202
GG49106.0 (98.0–118.0) 101.9 (15.8) 109.0 (94.0–115.0) 103.1 (14.7) 86.0 (77.0–92.0) 102.8 (11.7)
A60106.0 (95.0–113.0)0.806104.5 (16.6)0.215103.0 (91.0–114.3)0.318101.1 (13.4)0.60686.0 (77.8–92.0)0.863100.6 (13.8)0.694
G144106.0 (95.0–113.0) 101.6 (14.7) 106.0 (94.0–115.0) 102.2 (14.5) 86.0 (77.0–92.0) 101.3 (12.1)
SLC6A2 rs998424 (Dom)
GG41100.0 (95.0–112.0)0.211102.1 (14.5)0.862103.0 (91.0–113.5)0.363100.7 (15.3)0.49483.0 (77.0–92.0)0.36899.7 (12.8)0.362
AG + AA61108.0 (95.0–116.0) 102.7 (16.0) 106.0 (94.0–115.0) 102.7 (13.5) 86.0 (80.0–93.5) 102.0 (12.5)
G127103.0 (95.0–113.0)0.111102.8 (15.2)0.733106.0 (91.0–112.0)0.155101.9 (14.7)0.96986.0 (77.0–92.0)0.687100.5 (12.8)0.396
A77106.0 (96.5–116.0) 102.0 (15.6) 106.0 (94.0–116.5) 102.0 (13.4) 86.0 (77.0–95.0) 102.1 (12.4)
SNAP25 rs363039 (Dom)
GG45103.0 (92.0–111.0)0.026102.1 (14.1)0.825100.0 (91.0–107.5)0.01299.7 (12.8)0.16686.0 (80.0–93.5)0.51298.8 (11.8)0.096
AG + AA57108.0 (98.0–117.0) 102.8 (16.4) 109.0 (94.0–118.0) 103.6 (15.1) 83.0 (77.0–92.0) 103.0 (13.1)
G137106.0 (95.0–113.0)0.082102.1 (14.5)0.597103.0 (91.0–112.0)0.004100.8 (13.9)0.11386.0 (80.0–92.0)0.239100.1 (12.2)0.097
A67108.0 (95.0–118.0) 103.3 (17.0) 109.0 (94.0–118.0) 104.2 (14.6) 83.0 (77.0–92.0) 103.2 (13.3)
NTRK2 rs2289656 (Dom)
GG70108.0 (97.3–116.0)0.260103.3 (16.6)0.406106.0 (93.3–112.8)0.651102.7 (15.0)0.43684.5 (77.0–92.0)0.560101.7 (13.4)0.456
AG + AA32104.5 (92.0–112.5) 100.6 (12.2) 106.0 (94.0–115.0) 100.3 (12.4) 87.5 (77.0–95.0) 99.7 (10.9)
G167106.0 (95.0–116.0)0.181102.9 (15.9)0.372106.0 (94.0–112.0)0.428102.3 (14.6)0.39486.0 (77.0–92.0)0.695101.4 (13.0)0.414
A37103.0 (92.0–112.0) 100.4 (12.1) 106.0 (94.0–115.0) 100.1 (12.0) 86.0 (77.0–95.0) 99.6 (10.8)
NTRK2 rs10868235 (Dom)
GG27103.0 (93.0–113.0)0.29197.6 (11.5)0.052103.0 (91.0–112.0)0.40799.3 (11.7)0.26086.0 (77.0–95.0)0.92197.5 (11.3)0.083
AG + AA75108.0 (95.0–116.0) 104.2 (16.2) 106.0 (94.0–115.0) 102.9 (15.0) 86.0 (77.0–92.0) 102.4 (12.9)
G106106.0 (95.0–113.0)0.405100.8 (13.9)0.096106.0 (91.0–112.0)0.453101.1 (13.8)0.40986.0 (77.0–92.0)0.875100.0 (12.5)0.201
A98108.0 (97.3–113.0) 104.3 (16.6) 106.0 (94.0–115.0) 102.8 (14.6) 86.0 (77.0–92.0) 102.3 (12.7)
Dom: dominant model; Rec: recessive model. The bold indicates significant p values < 0.05. a Mann–Whitney test. b Student’s t-test.
Table 4. Influence of genetic polymorphisms on the cognitive profile assessed by WISC-V according to bisphenol exposure in children.
Table 4. Influence of genetic polymorphisms on the cognitive profile assessed by WISC-V according to bisphenol exposure in children.
Unadjusted Logistic Regression ModelsAdjusted Logistic Regression Models
Low Exposure (≤Median)High Exposure (>Median)Low Exposure (≤Median)High Exposure (>Median)
SNPIndexOR95% CIp ValueOR95% CIp ValueOR95% CIp ValueOR95% CIp Valuep for Interaction
BDNF rs11030101 (Ref. AA)
AA vs. AT + TT (Dom)VCI0.290.08–1.020.0530.910.28–2.890.8690.18 d0.04–0.850.0310.68 c0.18–2.590.5750.302
Ref. A vs. T 0.490.22–1.080.0781.190.53–2.700.6720.26 d0.09–0.730.0111.15 d0.50–2.640.7380.067
HTR2A rs6314 (Ref. GG)
GG vs. AG + AA (Dom)VCI0.340.08–1.480.1500.350.08–1.620.1800.15 d0.02–0.940.0420.21 d0.03–1.330.0980.820
Ref. G vs. A 0.320.08–1.290.1090.330.08–1.350.1220.22 d0.05–1.040.0550.23 d0.04–1.220.0840.946
HTR2A rs7997012 (Ref. AA)
AA + AG vs. GG (Rec)WMI3.961.23–12.730.0210.460.14–1.490.1936.30 d1.38–28.730.0170.27 d0.06–1.260.0960.002 *
Ref. A vs. G 2.741.08–6.940.0330.630.27–1.460.2813.42 b1.22–9.530.0190.49 d0.18–1.300.1520.007
MTHFR rs1801133 (Ref. GG)
GG vs. AG + AA (Dom)WMI0.280.09–0.910.0340.750.21–2.670.6570.24 c0.06–0.920.0380.55 d0.11–2.780.4670.272
Ref. G vs. A 0.310.13–0.730.0071.180.52–2.690.6890.28 c0.10–0.730.0101.20 a0.49–2.930.6860.026
MTHFR rs1801133 (Ref. GG)
GG vs. AG + AA (Dom)FSIQ0.380.12–1.210.1010.930.28–3.110.9020.32 d0.08–1.290.1110.68 d0.16–2.830.5990.226
Ref. G vs. A 0.420.18–0.970.0411.430.64–3.180.3820.36 b0.14–0.910.0301.43 a0.63–3.270.3930.025
OXTR rs53576 (Ref. AA)
AA + AG vs. GG (Rec)FRI0.490.15–1.610.2380.260.08–0.860.0280.69 d0.17–2.800.6000.20 d0.05–0.780.0200.315
Ref. A vs. G 0.740.29–1.910.5310.530.23–1.260.1520.99 d0.34–2.890.9810.51 a0.21–1.210.1260.370
OXTR rs53576 (Ref. AA)
AA + AG vs. GG (Rec)WMI0.910.30–2.740.8690.240.07–0.800.0211.08 d0.29–4.020.9050.08 d0.01–0.500.0070.030
Ref. A vs. G 0.970.40–2.310.9370.420.17–1.070.0701.14 d0.43–3.040.7870.27 d0.09–0.830.0230.066
SLC6A2 rs998424 (Ref. GG)
GG vs. AG + AA (Dom)FRI1.680.50–5.660.4030.180.05–0.600.0062.14 d0.53–8.640.2850.16 c0.04–0.570.005 *0.004 *
Ref. G vs. A 1.360.58–3.200.4760.300.13–0.710.0061.35 a0.56–3.260.5000.26 c0.11–0.650.004 *0.004 *
SNAP25 rs363039 (Ref. GG)
GG vs. AG + AA (Dom)FRI0.620.19–2.020.4300.190.06–0.680.0100.55 b0.16–1.940.3530.17 b0.04–0.630.0080.124
Ref. G vs. A 0.580.24–1.400.2260.270.11–0.640.0030.45 d0.16–1.260.1280.28 a0.12–0.680.005 *0.258
SNAP25 rs363039 (Ref. GG)
GG vs. AG + AA (Dom)WMI0.410.13–1.270.1240.560.17–1.860.3440.36 b0.11–1.190.0940.29 d0.07–1.270.0990.859
Ref. G vs. A 0.530.23–1.240.1440.510.22–1.170.1120.43 b0.17–1.090.0750.33 d0.11–0.950.0400.775
SNAP25 rs363039 (Ref. GG)
GG vs. AG + AA (Dom)FSIQ0.290.09–0.920.0350.410.13–1.330.1370.19 d0.05–0.820.0260.28 d0.07–1.090.0670.820
Ref. G vs. A 0.420.18–0.990.0470.570.25–1.300.1810.26 d0.09–0.780.0160.59 a0.25–1.370.2210.378
NTRK2 rs2289656 (Ref. GG)
GG vs. AG + AA (Dom)VCI3.430.99–11.930.0530.960.29–3.240.9519.06 c1.51–54.390.0160.96 d0.23–3.910.9510.088
Ref. G vs. A 2.971.05–8.440.0411.110.38–3.270.8446.72 d1.82–24.830.004 *0.89 b0.28–2.820.8370.062
NTRK2 rs10868235 (Ref. GG)
GG vs. AG + AA (Dom)VCI0.260.07–0.980.0460.790.21–2.950.7300.22 d0.04–1.080.0622.09 d0.41–10.720.3770.043
Ref. G vs. A 0.530.24–1.170.1170.930.42–2.040.8540.46 b0.19–1.130.0901.40 d0.58–3.370.4580.094
NTRK2 rs10868235 (Ref. GG)
GG vs. AG + AA (Dom)VSI0.310.08–1.300.1101.000.27–3.661.0000.18 d0.04–0.880.0345.35 d0.60–47.420.1320.020
Ref. G vs. A 0.920.41–2.060.8401.080.49–2.370.8410.66 b0.27–1.620.3621.56 b0.61–4.030.3570.199
Ref: reference category; Dom: dominant model; Rec: recessive model. Bold indicates significant p values < 0.05, and the asterisk (*) means significant p values after Bonferroni’s correction (p < 0.005). a Adjusted for gender and age. b Adjusted for gender, age, and BMI. c Adjusted for gender, age, and parental education level. d Adjusted for gender, age, BMI, and parental education level.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Ramírez, V.; González-Palacios, P.; González-Domenech, P.J.; Jaimez-Pérez, S.; Baca, M.A.; Rodrigo, L.; Álvarez-Cubero, M.J.; Monteagudo, C.; Martínez-González, L.J.; Rivas, A. Influence of Genetic Polymorphisms on Cognitive Function According to Dietary Exposure to Bisphenols in a Sample of Spanish Schoolchildren. Nutrients 2024, 16, 2639. https://doi.org/10.3390/nu16162639

AMA Style

Ramírez V, González-Palacios P, González-Domenech PJ, Jaimez-Pérez S, Baca MA, Rodrigo L, Álvarez-Cubero MJ, Monteagudo C, Martínez-González LJ, Rivas A. Influence of Genetic Polymorphisms on Cognitive Function According to Dietary Exposure to Bisphenols in a Sample of Spanish Schoolchildren. Nutrients. 2024; 16(16):2639. https://doi.org/10.3390/nu16162639

Chicago/Turabian Style

Ramírez, Viviana, Patricia González-Palacios, Pablo José González-Domenech, Sonia Jaimez-Pérez, Miguel A. Baca, Lourdes Rodrigo, María Jesús Álvarez-Cubero, Celia Monteagudo, Luis Javier Martínez-González, and Ana Rivas. 2024. "Influence of Genetic Polymorphisms on Cognitive Function According to Dietary Exposure to Bisphenols in a Sample of Spanish Schoolchildren" Nutrients 16, no. 16: 2639. https://doi.org/10.3390/nu16162639

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop